Assays for the Screening and Characterization of Tau Aggregation Inhibitors
Author:
Horsley David,
Rickard Janet E.,
Vorley Thomas,
Leeper Matilda F.,
Wischik Claude M.,
Harrington Charles R.ORCID
Reference17 articles.
1. Buée L, Bussière T, Buée-Scherrer V et al (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev 33:95–130
2. Novak M, Kabat J, Wischik CM (1993) Molecular characterization of the minimal protease resistant tau unit of the Alzheimer’s disease paired helical filament. EMBO J 12:365–370
3. Wischik CM, Novak M, Thøgersen HC et al (1988) Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer’s disease. Proc Natl Acad Sci U S A 85:4506–4510
4. Mukaetova-Ladinska EB, Garcia-Sierra F, Hurt J et al (2000) Staging of cytoskeletal and β-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer’s disease. Am J Pathol 157:623–636
5. Arriagada PW, Growdon JH, Hedley-White ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42:631–639